Intravenous Immunoglobulin (IVIG) for Resistant Neuropathic Pain

Clinical trial NCT00850005 · UNKNOWN

Trial details

NCT number: NCT00850005
Sponsor: University of Calgary
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Neuropathic Pain

Start date: 2009-02-01
Primary completion: 2010-07-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.